UPDATE: Morgan Stanley Downgrades Mylan to Equal-Weight Following Outperformance

Morgan Stanley downgraded Mylan Inc.

from Overweight to Equal-weight and removed the price target of $27.00. Morgan Stanley commented, "Mylan is above our previous $27 price target, and we are downgrading from OW to EW on a more balanced risk-reward. The market now appears to be pricing in better growth prospects in EMEA and the potential for accretive M&A." Mylan closed at $27.91 on Monday.